Targeting myeloid cell polarization to prevent GBM recurrence is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health National Cancer Institute
Grant: NIH R33 CA277820
National Institutes of Health National Cancer Institute
Grant: R01 CA281735
NCI NIH HHS
Grant: R33 CA277820
FWCI
0.00
Citation Percentile
0.5%
Fields of Study
Keywords